MOTHER OF SEVEN DIES AFTER USING OXYELITE PRO
The Huffington Post has reported that a forty-eight year old mother of seven has died from liver failure on October 4, 2013. Reportedly, she started taking OxyElite Pro to lose weight and quickly fell severely ill. She was deemed ineligible for a liver transplant after doctors discovered that she had cancer.
STUDY FINDS NO BENEFIT IN VOICE TO TEXT APPS
A recent study sponsored by the Southwest Region University Transportation Center and conducted by the Texas A&M Transportation Institute is a first of its kind study to measure the performance of drivers who used manually texting while driving vs. voice to text apps while driving. The results show no real benefit in the use of […]
US DOT Shuts Down Trucking Company for Safety Violations
Were you or a loved one seriously injured or killed in a Semi-Truck crash? Contact Us Today A Laredo, Texas based company is shut down by the US Department of Transportation (US DOT) for repeated and significant safety violations. After a crash in mid-August, 2013, the Federal Motor Carrier Safety Administration (FMCSA) instituted an […]
FURLOUGHED GOVERNMENT WORKERS RECALLED TO INVESTIGATE OXYELITE PRO
ABC and CBS News are reporting that the US Food and Drug Administration has recalled “a couple” of technical experts to help investigate the hepatitis outbreak in Hawaii for a possible link to the dietary supplement OxyElite Pro. The FDA is prioritizing the work of its investigators who have not been furloughed to investigate matters […]
CDC Health Advisory Issued Due to Hepatitis Outbreak Linked to OxyElite Pro
Summary: On October 8, 2013, the Center for Disease Control and Prevention (“CDC”) issued a Health Advisory for OxyElite Pro due to reports of acute hepatitis cases linked to the product’s use. A number of previously healthy individuals developed acute hepatitis and sudden liver failure of unknown cause after using OxyElite Pro for weight loss […]
FDA Finalizes New System to Identify Medical Devices
According to an FDA news release posted on September 20, 2013, the U.S. Food and Drug Administration (“FDA”) is launching a new system for identifying high-risk medical devices such as hip and knee implants. The agency announced that its new Unique Device Identification System (UDI) will provide a consistent and simpler way to identify medical […]
F.D.A. Requires Drug Manufacturers to Change Labels and Warn of Risk of Nerve Damage for Patients taking Oral and Injectable Fluoroquinolone Drugs
Summary On August 15, 2013, the U.S. Food and Drug Administration (F.D.A.) issued a safety announcement advising the public that manufacturers of fluoroquinolone drugs are required to change drug labels to provide a more adequate warning to patients of the risk of permanent nerve damage that may be associated with taking these kinds of drugs.
DePuy Pinnacle Litigation Update
A DePuy Pinnacle Multi-district litigation (“MDL”) status conference was held on September 10, 2013 at the U.S. District courthouse in Dallas, Texas. The conference was held before the Honorable Ed Kinkeade, the judge overseeing the federal multidistrict litigation against DePuy Orthopaedics, Inc. and Johnson & Johnson, Inc. regarding the DePuy Pinnacle hip replacement devices.
Judge Overrules Biomet’s Preemption Claims
On August 21, 2013, Judge Robert L. Miller, Jr., the Judge presiding over the consolidated litigation in federal court regarding the Biomet M2a Magnum, rejected Biomet’s preemption argument to obtain dismissal of a lawsuit filed by Leslie and Allison Caccia.
FDA Requires Packaging Changes to Fentanyl Patches
The FDA issued a Safety Alert requiring all manufacturers of Fentanyl patches, brand name Duragesic, to change the packaging to make the name and strength of the patches more visible. This Safety Alert comes after the FDA has received reports of deaths from accidental exposure to fentanyl patches.